May 31 |
Beyond Air Up 11%, Insiders Still Down After US$3.05m Purchase
|
May 23 |
Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
|
May 1 |
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
|
Mar 20 |
Beyond Air rises after pricing its $16M direct offering
|
Mar 20 |
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
|
Feb 13 |
Beyond Air, Inc. (XAIR) Q3 2024 Earnings Call Transcript
|
Feb 12 |
Beyond Air GAAP EPS of -$0.50 beats by $0.04, revenue of $0.4M misses by $0.05M
|
Feb 12 |
Recap: Beyond Air Q3 Earnings
|
Feb 12 |
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024
|
Jan 18 |
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
|